<DOC>
	<DOCNO>NCT01031745</DOCNO>
	<brief_summary>Drug use ( DU ) major risk factor HIV infection many region world . However , highly active antiretroviral therapy ( HAART ) roll South South East Asia , less 2 % individual initiate HAART drug user ( DUs ) former DUs , despite fact approximately 20 % HIV infection region ascribe DU . India home 2.4 million HIV-infected individual . Though , injection drug user contribute 3 % HIV infection India ; estimate 168,000 1.1 million DUs India HIV prevalence 30 % . Novel approach need engage disenfranchised population HIV care lower middle income country , burden HIV disease grow . Incentive-based strategy ( contingency management ) show effective reduce illicit drug use , smoke cessation , weight loss . Short-term pilot study also show incentive-based strategy improve electronically-monitored rate adherence HAART US , recent study Africa show small incentive approximately double rate individual return learn result HIV test . However , date experience use incentive-based intervention improve engagement care risk-reduction among out-of-care HIV-infected DUs develop world setting . The investigator propose conduct pilot randomize trial compare voucher incentive strategy control condition improve engagement HIV care HIV treatment outcome among out-of-care , treatment-eligible , HIV-infected DUs Chennai , India . Subjects incentive arm eligible earn incentive voucher 1 ) initiate HAART government-sanctioned HIV treatment clinic , 2 ) adherence schedule follow-up visit HIV clinic , 3 ) achieve suppression HIV RNA . Subjects enrol mature research venue Chennai , YR Gaitonde Centre Substance Abuse-related Research ( YRGCSAR ) , focus epidemiology natural history HIV DUs . Preliminary data pilot study use inform design phase-III study .</brief_summary>
	<brief_title>Contingency Management Delivery HAART Drug Users Chennai , India</brief_title>
	<detailed_description />
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Substance Abuse , Intravenous</mesh_term>
	<criteria>18 year age old Provide write informed consent Provide history injection noninjection drug use prior 30 day Documented evidence HIV infection Be ART naïve ( selfreport ) Satisfy Indian National Guidelines initiation HAART ( follow ) Absolute CD4+ count &lt; 200 cells/ µl AIDSdefining illness CD4+ count Absolute CD4+ count 200 350 cell/ µl HIVrelated symptom Indicates intention migrate next 12 month Any medical psychiatric condition study physician believe contraindication study participation . Enrolled another HIV treatment program</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Complementary Therapies</keyword>
	<keyword>Drug Users</keyword>
</DOC>